# reload+after+2024-01-22 14:44:12.948936
address1§11055 Flintkote Avenue
city§San Diego
state§CA
zip§92121
country§United States
phone§858 952 7570
website§https://www.cardiffoncology.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and hematologic malignancies, such as KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. It primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
fullTimeEmployees§25
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Mark  Erlander Ph.D.', 'age': 63, 'title': 'CEO & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 2427422, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. James E. Levine', 'age': 52, 'title': 'Chief Financial Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 1568206, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tod  Smeal Ph.D.', 'age': 58, 'title': 'Chief Scientific Officer?', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 2686374, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Elizabeth  Anderson', 'title': 'VP of Finance & Administration', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Brigitte  Lindsay', 'title': 'Senior Vice President of Finance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Charles  Monahan R.Ph.', 'title': 'Senior VP of Regulatory Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Fairooz  Kabbinavar FACP, M.D.', 'age': 65, 'title': 'Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.728
priceToSalesTrailing12Months§152.48523
currency§USD
dateShortInterest§1702598400
forwardEps§-1.2
exchange§NCM
quoteType§EQUITY
shortName§Cardiff Oncology, Inc.
longName§Cardiff Oncology, Inc.
firstTradeDateEpochUtc§1090935000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§66310195-132e-37e2-aefd-b05ac5a2eb8a
gmtOffSetMilliseconds§-18000000
targetHighPrice§12.0
targetLowPrice§5.0
targetMeanPrice§8.5
targetMedianPrice§8.5
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§9.044
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
